Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Financial Results:
Torrent Pharmaceuticals Ltd reported Revenues for Q4FY24 of ₹2,745.00 Crores up from ₹2,491.00 Crore year on year, a rise of 10.2%.
Total Expenses for Q4FY24 of ₹2,145.00 Crores up from ₹2,067.00 Crores year on year, a rise of 3.77%.
Consolidated Net Profit of ₹449.00 Crores up 56.45% from ₹287.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹13.27, up 56.49% from ₹8.48 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.